data_1zpx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zpx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.562 1.89 0 N-CA-C 114.923 1.086 . . . . 0.0 114.923 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 13.4 m -75.75 -45.01 38.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.77 -75.51 1.96 Allowed Glycine 0 CA--C 1.539 1.587 0 O-C-N 124.053 0.846 . . . . 0.0 112.415 -162.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -134.47 -33.72 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.333 1.4 p90 -69.9 -21.59 63.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -171.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 54.5 m -149.58 153.14 36.39 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 119.781 1.173 . . . . 0.0 111.703 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -56.91 108.34 0.34 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.391 2.727 . . . . 0.0 112.344 157.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.596 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 27.9 p -81.96 17.47 1.56 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 175.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.71 -29.5 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 148.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -71.35 0.87 7.13 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 153.86 15.01 Favored Pre-proline 0 CA--C 1.566 1.567 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -113.29 27.45 1.86 Allowed 'Cis proline' 0 C--N 1.367 1.541 0 N-CA-C 119.471 2.835 . . . . 0.0 119.471 10.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.24 81.5 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 161.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.8 m 56.28 61.79 2.59 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 124.038 0.935 . . . . 0.0 110.711 -162.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -94.61 137.99 22.4 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 115.73 -2.081 . . . . 0.0 113.064 -148.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.99 -27.25 0.88 Allowed 'Trans proline' 0 CA--C 1.562 1.887 0 N-CA-C 121.602 3.655 . . . . 0.0 121.602 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.277 31.5 m -73.25 -40.68 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 167.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.8 t -72.25 -30.11 64.57 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 3.8 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.562 1.878 0 N-CA-C 114.788 1.034 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 18.2 m -78.38 -45.5 22.28 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -167.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.19 -75.41 1.9 Allowed Glycine 0 CA--C 1.543 1.807 0 O-C-N 123.924 0.765 . . . . 0.0 111.957 -159.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.8 m -139.08 -34.17 0.6 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.336 1.9 p90 -65.98 -27.49 68.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -135.32 155.4 78.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 123.78 0.832 . . . . 0.0 111.052 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.36 110.91 0.47 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.121 2.548 . . . . 0.0 112.814 144.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.531 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 57.0 p -79.13 20.57 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 173.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.06 -33.88 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 151.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.26 6.46 1.32 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 162.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.68 151.78 70.24 Favored Pre-proline 0 CA--C 1.567 1.619 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -108.75 25.57 5.47 Favored 'Cis proline' 0 C--N 1.367 1.545 0 N-CA-C 118.822 2.585 . . . . 0.0 118.822 9.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.67 87.91 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 158.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m 54.42 59.87 3.9 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.746 0.818 . . . . 0.0 111.374 -160.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -84.07 151.27 60.02 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -146.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.89 -16.79 0.22 Allowed 'Trans proline' 0 CA--C 1.564 2.013 0 N-CA-C 120.889 3.38 . . . . 0.0 120.889 165.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.51 -48.2 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.17 -28.14 66.14 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.4 m . . . . . 0 CA--C 1.56 1.343 0 C-N-CA 124.358 1.063 . . . . 0.0 113.137 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 CA--C 1.559 1.735 0 N-CA-C 114.422 0.893 . . . . 0.0 114.422 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.6 m -85.72 -44.35 12.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.63 -84.23 1.59 Allowed Glycine 0 CA--C 1.537 1.433 0 O-C-N 123.697 0.623 . . . . 0.0 114.144 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -83.55 -38.13 22.1 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.314 0.4 OUTLIER -83.23 -13.41 55.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 176.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -154.76 152.99 26.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 120.485 1.493 . . . . 0.0 112.189 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -51.62 102.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.645 2.897 . . . . 0.0 113.042 148.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -83.27 26.34 0.65 Allowed 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.86 -34.38 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 148.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.3 m -68.07 4.69 1.13 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 162.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.84 152.07 50.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -108.28 22.28 6.38 Favored 'Cis proline' 0 C--N 1.367 1.528 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 7.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.39 98.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 162.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 m 56.64 57.54 4.73 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.013 1.325 . . . . 0.0 110.926 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.08 148.6 45.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 116.708 -1.615 . . . . 0.0 113.494 -146.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.68 -13.69 0.09 OUTLIER 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 121.359 3.561 . . . . 0.0 121.359 169.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.265 59.1 t -88.96 -39.88 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.56 -35.37 78.9 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.666 1.575 . . . . 0.0 115.054 163.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.564 2.009 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 35.4 m -80.24 -50.41 10.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.83 -87.86 1.56 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.278 -165.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -95.42 -55.24 3.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' O ' ' SG ' ' A' ' 31' ' ' CYS 0.335 0.8 OUTLIER -82.6 2.96 30.72 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -158.71 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -164.67 154.61 12.21 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 120.247 1.385 . . . . 0.0 113.052 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.39 108.79 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.63 2.887 . . . . 0.0 113.183 148.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.505 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 47.5 p -82.24 21.1 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.3 -33.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 151.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 m -72.67 8.59 1.39 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 162.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.23 150.62 71.0 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -108.54 23.57 5.97 Favored 'Cis proline' 0 C--N 1.365 1.439 0 N-CA-C 119.067 2.68 . . . . 0.0 119.067 8.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.77 92.23 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 163.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.3 m 56.83 56.35 5.5 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.411 1.084 . . . . 0.0 111.565 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.49 139.74 31.77 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 116.334 -1.793 . . . . 0.0 112.455 -144.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 -24.45 0.25 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 N-CA-C 120.838 3.361 . . . . 0.0 120.838 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.283 6.5 p -72.25 -44.66 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 168.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.7 m -70.77 -29.56 65.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 165.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 CA--C 1.558 1.713 0 N-CA-C 114.501 0.923 . . . . 0.0 114.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.13 -38.49 14.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 -78.16 1.99 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -79.8 -39.31 31.09 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.644 2.461 . . . . 0.0 117.644 -164.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE1' ' SG ' ' A' ' 26' ' ' CYS 0.335 0.5 OUTLIER -86.31 -10.55 54.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 174.335 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -147.27 151.38 40.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 CA-C-N 120.729 1.604 . . . . 0.0 111.771 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 24.2 Cg_exo -57.9 88.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.421 2.747 . . . . 0.0 112.142 148.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 32.59 0.57 Allowed 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.77 -34.46 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.416 -0.802 . . . . 0.0 112.599 148.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 19' ' ' PRO . 17.9 p -68.3 8.22 0.48 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 162.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.44 156.57 0.33 Allowed Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -113.51 19.15 1.99 Allowed 'Cis proline' 0 C--N 1.37 1.661 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 11.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.48 -37.47 82.93 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 161.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 17' ' ' TYR 0.293 14.2 p 49.56 57.05 6.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.528 1.531 . . . . 0.0 112.139 -166.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -86.07 148.69 48.46 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 116.813 -1.565 . . . . 0.0 113.678 -150.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.49 -12.54 0.19 Allowed 'Trans proline' 0 CA--C 1.564 1.991 0 N-CA-C 121.856 3.752 . . . . 0.0 121.856 171.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -96.97 -33.47 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 167.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.68 -38.77 86.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 160.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.8 m . . . . . 0 CA--C 1.557 1.242 0 C-N-CA 125.043 1.337 . . . . 0.0 113.746 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.559 1.766 0 N-CA-C 114.536 0.937 . . . . 0.0 114.536 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -85.8 -48.96 8.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 37.27 49.22 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 121.227 3.251 . . . . 0.0 121.227 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 t -162.43 -50.07 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.416 0.686 . . . . 0.0 112.357 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.27 1.4 p90 -96.28 1.9 52.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.35 150.54 14.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 120.718 1.599 . . . . 0.0 111.458 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.34 100.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.441 2.761 . . . . 0.0 112.665 148.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.9 p -86.93 23.39 1.76 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.71 -35.03 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 144.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 33.6 t -79.46 25.04 0.33 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 162.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 161.99 38.48 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -110.72 18.92 3.72 Favored 'Cis proline' 0 C--N 1.369 1.606 0 N-CA-C 119.39 2.804 . . . . 0.0 119.39 6.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.54 90.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 161.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.6 m 57.58 55.59 5.52 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.854 1.262 . . . . 0.0 111.035 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.502 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -88.96 140.17 29.14 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 115.759 -2.067 . . . . 0.0 112.168 -149.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -36.72 -31.86 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.116 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.261 7.0 p -74.21 -41.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.22 -35.07 79.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 160.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 9.8 m . . . . . 0 CA--C 1.575 1.926 0 C-N-CA 125.318 1.447 . . . . 0.0 113.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 0 CA--C 1.561 1.828 0 N-CA-C 114.558 0.946 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.408 ' H ' ' CB ' ' A' ' 20' ' ' SER . 80.1 m -90.31 -44.61 9.58 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.25 -77.83 1.99 Allowed Glycine 0 CA--C 1.539 1.551 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.5 t -74.34 -46.62 39.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.294 0.5 OUTLIER -87.01 -5.34 59.11 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 176.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -153.37 144.58 16.26 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-N 120.009 1.277 . . . . 0.0 110.764 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.35 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.567 2.845 . . . . 0.0 111.867 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.408 ' CB ' ' H ' ' A' ' 14' ' ' CYS . 48.7 m -94.1 35.25 1.18 Allowed 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.406 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.6 t -76.33 -39.85 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.51 -0.744 . . . . 0.0 111.671 142.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.33 14.13 0.1 Allowed 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 161.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.18 165.85 0.07 OUTLIER Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 120.244 3.424 . . . . 0.0 120.244 163.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -108.33 4.54 6.29 Favored 'Cis proline' 0 C--N 1.373 1.834 0 N-CA-C 120.626 3.279 . . . . 0.0 120.626 7.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.34 -22.2 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 168.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.73 51.78 5.98 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.483 1.113 . . . . 0.0 112.288 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.15 156.05 49.08 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 117.088 -1.434 . . . . 0.0 114.339 -151.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.69 2.89 0.46 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 N-CA-C 119.658 2.907 . . . . 0.0 119.658 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -106.32 -27.07 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 161.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.5 m -60.09 -45.69 92.11 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.206 1.366 . . . . 0.0 114.05 155.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m . . . . . 0 N--CA 1.486 1.375 0 C-N-CA 125.27 1.428 . . . . 0.0 113.643 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.558 1.679 0 N-CA-C 115.056 1.137 . . . . 0.0 115.056 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 4.7 p -79.95 -55.11 5.2 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.08 -81.84 1.39 Allowed Glycine 0 CA--C 1.54 1.647 0 O-C-N 123.625 0.578 . . . . 0.0 114.039 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -83.13 -39.45 21.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.919 2.562 . . . . 0.0 117.919 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.321 0.9 OUTLIER -76.74 -21.89 54.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 174.587 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 76.8 m -153.8 148.5 19.6 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-N 119.109 0.868 . . . . 0.0 111.434 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.81 107.58 0.19 Allowed 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 123.983 3.122 . . . . 0.0 113.488 155.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.592 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.3 p -90.97 36.72 0.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.3 -40.96 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.478 155.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.1 15.07 0.12 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.436 2.754 . . . . 0.0 118.436 162.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.22 151.02 7.55 Favored Pre-proline 0 CA--C 1.565 1.539 0 N-CA-C 118.615 2.821 . . . . 0.0 118.615 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -98.68 15.4 28.79 Favored 'Cis proline' 0 N--CA 1.494 1.515 0 N-CA-C 118.982 2.647 . . . . 0.0 118.982 3.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.33 82.27 1.82 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.577 1.656 . . . . 0.0 107.609 159.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.5 m 27.24 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 120.269 3.433 . . . . 0.0 120.269 71.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -106.65 154.16 40.21 Favored Pre-proline 0 N--CA 1.482 1.159 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.319 -159.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 -19.03 0.4 Allowed 'Trans proline' 0 CA--C 1.563 1.941 0 N-CA-C 122.336 3.937 . . . . 0.0 122.336 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.74 -42.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.43 -36.54 84.08 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.2 m . . . . . 0 N--CA 1.486 1.362 0 C-N-CA 124.801 1.241 . . . . 0.0 113.966 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.556 1.606 0 N-CA-C 114.254 0.828 . . . . 0.0 114.254 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -134.67 -71.36 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.51 0.724 . . . . 0.0 111.341 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.15 68.05 1.17 Allowed Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.4 t -160.07 90.44 0.9 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.415 30.3 p90 55.01 11.69 0.53 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -129.49 150.18 74.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 119.824 1.193 . . . . 0.0 113.504 -169.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.15 99.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.332 2.688 . . . . 0.0 111.828 142.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.2 p -74.73 12.9 0.72 Allowed 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -66.23 -26.76 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 153.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.4 p -108.37 58.0 0.61 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 123.208 1.48 . . . . 0.0 114.009 153.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.96 165.41 1.79 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 145.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -114.14 12.09 2.09 Favored 'Cis proline' 0 CA--C 1.56 1.782 0 N-CA-C 119.839 2.977 . . . . 0.0 119.839 8.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 162.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 65.97 59.57 0.7 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.592 1.157 . . . . 0.0 108.258 -166.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.87 143.1 29.6 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.635 -146.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -50.43 -13.69 0.83 Allowed 'Trans proline' 0 CA--C 1.568 2.187 0 N-CA-C 120.964 3.409 . . . . 0.0 120.964 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 m -100.07 -29.9 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 160.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.8 m . . . . . 0 CA--C 1.556 1.21 0 C-N-CA 125.238 1.415 . . . . 0.0 113.843 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo . . . . . 0 CA--C 1.558 1.681 0 N-CA-C 114.424 0.894 . . . . 0.0 114.424 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.4 -37.29 12.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.62 -84.06 1.6 Allowed Glycine 0 CA--C 1.538 1.528 0 N-CA-C 114.434 0.533 . . . . 0.0 114.434 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.4 m -83.49 -40.11 19.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -162.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.309 0.6 OUTLIER -83.78 -8.95 59.12 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.55 149.95 25.43 Favored Pre-proline 0 N--CA 1.486 1.326 0 CA-C-N 120.058 1.299 . . . . 0.0 111.385 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -54.84 99.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.328 2.686 . . . . 0.0 112.229 149.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -87.84 23.2 2.09 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -39.72 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.392 -0.817 . . . . 0.0 111.736 147.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.5 t -73.82 17.69 0.16 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 162.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.58 165.75 0.21 Allowed Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 164.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -110.3 7.1 4.45 Favored 'Cis proline' 0 C--N 1.372 1.785 0 N-CA-C 120.698 3.307 . . . . 0.0 120.698 7.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.03 -25.16 62.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 166.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.27 53.24 5.45 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -93.42 155.49 40.79 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.264 -151.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.55 -14.22 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 N-CA-C 122.442 3.978 . . . . 0.0 122.442 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.23 -29.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.67 -46.61 86.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.624 1.556 . . . . 0.0 114.068 154.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 125.755 1.622 . . . . 0.0 110.784 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.255 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.82 174.1 13.3 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 124.735 3.624 . . . . 0.0 114.923 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 13.4 m -75.75 -45.01 38.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.77 -75.51 1.96 Allowed Glycine 0 CA--C 1.539 1.587 0 O-C-N 124.053 0.846 . . . . 0.0 112.415 -162.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -134.47 -33.72 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.333 1.4 p90 -69.9 -21.59 63.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -171.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 54.5 m -149.58 153.14 36.39 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 119.781 1.173 . . . . 0.0 111.703 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -56.91 108.34 0.34 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.391 2.727 . . . . 0.0 112.344 157.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.596 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 27.9 p -81.96 17.47 1.56 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 175.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.71 -29.5 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 148.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -71.35 0.87 7.13 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 153.86 15.01 Favored Pre-proline 0 CA--C 1.566 1.567 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -113.29 27.45 1.86 Allowed 'Cis proline' 0 C--N 1.367 1.541 0 N-CA-C 119.471 2.835 . . . . 0.0 119.471 10.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.24 81.5 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 161.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.8 m 56.28 61.79 2.59 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 124.038 0.935 . . . . 0.0 110.711 -162.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -94.61 137.99 22.4 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 115.73 -2.081 . . . . 0.0 113.064 -148.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.99 -27.25 0.88 Allowed 'Trans proline' 0 CA--C 1.562 1.887 0 N-CA-C 121.602 3.655 . . . . 0.0 121.602 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.277 31.5 m -73.25 -40.68 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 167.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.8 t -72.25 -30.11 64.57 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 3.8 m -72.11 -46.45 56.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -122.13 88.54 48.32 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -161.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.35 123.85 6.23 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.75 2.3 . . . . 0.0 112.949 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.395 0 O-C-N 119.903 -1.748 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.46 177.56 8.5 Favored 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 124.635 3.557 . . . . 0.0 114.788 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.531 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 18.2 m -78.38 -45.5 22.28 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -167.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.19 -75.41 1.9 Allowed Glycine 0 CA--C 1.543 1.807 0 O-C-N 123.924 0.765 . . . . 0.0 111.957 -159.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.8 m -139.08 -34.17 0.6 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.336 1.9 p90 -65.98 -27.49 68.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -135.32 155.4 78.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 123.78 0.832 . . . . 0.0 111.052 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.36 110.91 0.47 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.121 2.548 . . . . 0.0 112.814 144.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.531 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 57.0 p -79.13 20.57 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 173.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.06 -33.88 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 151.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.26 6.46 1.32 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 162.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.68 151.78 70.24 Favored Pre-proline 0 CA--C 1.567 1.619 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -108.75 25.57 5.47 Favored 'Cis proline' 0 C--N 1.367 1.545 0 N-CA-C 118.822 2.585 . . . . 0.0 118.822 9.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.67 87.91 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 158.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m 54.42 59.87 3.9 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.746 0.818 . . . . 0.0 111.374 -160.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -84.07 151.27 60.02 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -146.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.89 -16.79 0.22 Allowed 'Trans proline' 0 CA--C 1.564 2.013 0 N-CA-C 120.889 3.38 . . . . 0.0 120.889 165.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.51 -48.2 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.17 -28.14 66.14 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.4 m -73.87 -47.81 35.52 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.358 1.063 . . . . 0.0 113.137 173.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -126.91 85.68 60.45 Favored Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -169.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.15 121.58 4.45 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.715 2.277 . . . . 0.0 112.88 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 O-C-N 119.913 -1.742 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.43 162.51 19.58 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 124.586 3.524 . . . . 0.0 114.422 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.6 m -85.72 -44.35 12.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.63 -84.23 1.59 Allowed Glycine 0 CA--C 1.537 1.433 0 O-C-N 123.697 0.623 . . . . 0.0 114.144 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -83.55 -38.13 22.1 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.314 0.4 OUTLIER -83.23 -13.41 55.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 176.607 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -154.76 152.99 26.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 120.485 1.493 . . . . 0.0 112.189 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -51.62 102.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.645 2.897 . . . . 0.0 113.042 148.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -83.27 26.34 0.65 Allowed 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.86 -34.38 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 148.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.3 m -68.07 4.69 1.13 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 162.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.84 152.07 50.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -108.28 22.28 6.38 Favored 'Cis proline' 0 C--N 1.367 1.528 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 7.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.39 98.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 162.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 m 56.64 57.54 4.73 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.013 1.325 . . . . 0.0 110.926 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.08 148.6 45.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 116.708 -1.615 . . . . 0.0 113.494 -146.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.68 -13.69 0.09 OUTLIER 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 121.359 3.561 . . . . 0.0 121.359 169.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.265 59.1 t -88.96 -39.88 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.56 -35.37 78.9 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.666 1.575 . . . . 0.0 115.054 163.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m -71.45 -47.01 58.44 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -125.86 87.16 56.45 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.35 122.07 4.5 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.521 2.147 . . . . 0.0 112.946 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.438 0 O-C-N 119.918 -1.739 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.79 -178.42 4.59 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 124.584 3.523 . . . . 0.0 114.869 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 35.4 m -80.24 -50.41 10.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.83 -87.86 1.56 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.278 -165.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -95.42 -55.24 3.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' O ' ' SG ' ' A' ' 31' ' ' CYS 0.335 0.8 OUTLIER -82.6 2.96 30.72 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -158.71 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -164.67 154.61 12.21 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 120.247 1.385 . . . . 0.0 113.052 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.39 108.79 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.63 2.887 . . . . 0.0 113.183 148.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.505 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 47.5 p -82.24 21.1 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.3 -33.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 151.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 m -72.67 8.59 1.39 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 162.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.23 150.62 71.0 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -108.54 23.57 5.97 Favored 'Cis proline' 0 C--N 1.365 1.439 0 N-CA-C 119.067 2.68 . . . . 0.0 119.067 8.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.77 92.23 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 163.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.3 m 56.83 56.35 5.5 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.411 1.084 . . . . 0.0 111.565 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.49 139.74 31.77 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 116.334 -1.793 . . . . 0.0 112.455 -144.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 -24.45 0.25 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 N-CA-C 120.838 3.361 . . . . 0.0 120.838 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.283 6.5 p -72.25 -44.66 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 168.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.7 m -70.77 -29.56 65.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 165.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m -73.25 -45.9 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -121.92 89.26 48.12 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -163.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.85 123.39 5.76 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.816 2.344 . . . . 0.0 113.027 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 119.944 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.29 158.6 29.69 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 124.541 3.494 . . . . 0.0 114.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.13 -38.49 14.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 -78.16 1.99 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -79.8 -39.31 31.09 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.644 2.461 . . . . 0.0 117.644 -164.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE1' ' SG ' ' A' ' 26' ' ' CYS 0.335 0.5 OUTLIER -86.31 -10.55 54.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 174.335 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -147.27 151.38 40.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 CA-C-N 120.729 1.604 . . . . 0.0 111.771 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 24.2 Cg_exo -57.9 88.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.421 2.747 . . . . 0.0 112.142 148.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 32.59 0.57 Allowed 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.77 -34.46 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.416 -0.802 . . . . 0.0 112.599 148.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 19' ' ' PRO . 17.9 p -68.3 8.22 0.48 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 162.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.44 156.57 0.33 Allowed Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -113.51 19.15 1.99 Allowed 'Cis proline' 0 C--N 1.37 1.661 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 11.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.48 -37.47 82.93 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 161.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 17' ' ' TYR 0.293 14.2 p 49.56 57.05 6.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.528 1.531 . . . . 0.0 112.139 -166.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -86.07 148.69 48.46 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 116.813 -1.565 . . . . 0.0 113.678 -150.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.49 -12.54 0.19 Allowed 'Trans proline' 0 CA--C 1.564 1.991 0 N-CA-C 121.856 3.752 . . . . 0.0 121.856 171.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -96.97 -33.47 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 167.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.68 -38.77 86.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 160.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.8 m -73.46 -52.01 15.18 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.043 1.337 . . . . 0.0 113.746 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -126.58 83.52 64.61 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 123.15 5.49 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.794 2.329 . . . . 0.0 113.038 -171.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.444 0 O-C-N 119.834 -1.791 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.13 160.94 18.0 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 124.574 3.516 . . . . 0.0 114.536 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -85.8 -48.96 8.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 37.27 49.22 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 121.227 3.251 . . . . 0.0 121.227 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 t -162.43 -50.07 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.416 0.686 . . . . 0.0 112.357 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.27 1.4 p90 -96.28 1.9 52.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.35 150.54 14.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 120.718 1.599 . . . . 0.0 111.458 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.34 100.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.441 2.761 . . . . 0.0 112.665 148.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.9 p -86.93 23.39 1.76 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.71 -35.03 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 144.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 33.6 t -79.46 25.04 0.33 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 162.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 161.99 38.48 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -110.72 18.92 3.72 Favored 'Cis proline' 0 C--N 1.369 1.606 0 N-CA-C 119.39 2.804 . . . . 0.0 119.39 6.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.54 90.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 161.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.6 m 57.58 55.59 5.52 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.854 1.262 . . . . 0.0 111.035 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.502 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -88.96 140.17 29.14 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 115.759 -2.067 . . . . 0.0 112.168 -149.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -36.72 -31.86 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.116 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.261 7.0 p -74.21 -41.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.22 -35.07 79.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 160.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 9.8 m -73.45 171.05 13.84 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 125.318 1.447 . . . . 0.0 113.205 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -127.4 130.69 23.67 Favored Pre-proline 0 CA--C 1.566 1.588 1 O-C-N 114.582 -5.074 . . . . 0.0 109.586 11.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 124.44 6.2 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.986 2.457 . . . . 0.0 112.978 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 O-C-N 119.968 -1.708 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -83.29 164.05 14.92 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 124.618 3.545 . . . . 0.0 114.558 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.408 ' H ' ' CB ' ' A' ' 20' ' ' SER . 80.1 m -90.31 -44.61 9.58 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.25 -77.83 1.99 Allowed Glycine 0 CA--C 1.539 1.551 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.5 t -74.34 -46.62 39.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.294 0.5 OUTLIER -87.01 -5.34 59.11 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 176.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -153.37 144.58 16.26 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-N 120.009 1.277 . . . . 0.0 110.764 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.35 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.567 2.845 . . . . 0.0 111.867 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.408 ' CB ' ' H ' ' A' ' 14' ' ' CYS . 48.7 m -94.1 35.25 1.18 Allowed 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.406 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.6 t -76.33 -39.85 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.51 -0.744 . . . . 0.0 111.671 142.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.33 14.13 0.1 Allowed 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 161.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.18 165.85 0.07 OUTLIER Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 120.244 3.424 . . . . 0.0 120.244 163.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -108.33 4.54 6.29 Favored 'Cis proline' 0 C--N 1.373 1.834 0 N-CA-C 120.626 3.279 . . . . 0.0 120.626 7.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.34 -22.2 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 168.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.73 51.78 5.98 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.483 1.113 . . . . 0.0 112.288 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.15 156.05 49.08 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 117.088 -1.434 . . . . 0.0 114.339 -151.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.69 2.89 0.46 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 N-CA-C 119.658 2.907 . . . . 0.0 119.658 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -106.32 -27.07 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 161.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.5 m -60.09 -45.69 92.11 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.206 1.366 . . . . 0.0 114.05 155.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m -77.41 -47.18 20.45 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.27 1.428 . . . . 0.0 113.643 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -124.6 82.81 58.94 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.06 -61.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.559 1.771 0 C-N-CA 122.816 2.344 . . . . 0.0 115.087 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.232 0 O-C-N 119.018 -2.301 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.322 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 168.48 24.7 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 124.647 3.565 . . . . 0.0 115.056 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 4.7 p -79.95 -55.11 5.2 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.08 -81.84 1.39 Allowed Glycine 0 CA--C 1.54 1.647 0 O-C-N 123.625 0.578 . . . . 0.0 114.039 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -83.13 -39.45 21.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.919 2.562 . . . . 0.0 117.919 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.321 0.9 OUTLIER -76.74 -21.89 54.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 174.587 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 76.8 m -153.8 148.5 19.6 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-N 119.109 0.868 . . . . 0.0 111.434 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.81 107.58 0.19 Allowed 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 123.983 3.122 . . . . 0.0 113.488 155.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.592 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.3 p -90.97 36.72 0.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.3 -40.96 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.478 155.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.1 15.07 0.12 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.436 2.754 . . . . 0.0 118.436 162.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.22 151.02 7.55 Favored Pre-proline 0 CA--C 1.565 1.539 0 N-CA-C 118.615 2.821 . . . . 0.0 118.615 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -98.68 15.4 28.79 Favored 'Cis proline' 0 N--CA 1.494 1.515 0 N-CA-C 118.982 2.647 . . . . 0.0 118.982 3.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.33 82.27 1.82 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.577 1.656 . . . . 0.0 107.609 159.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.5 m 27.24 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 120.269 3.433 . . . . 0.0 120.269 71.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -106.65 154.16 40.21 Favored Pre-proline 0 N--CA 1.482 1.159 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.319 -159.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 -19.03 0.4 Allowed 'Trans proline' 0 CA--C 1.563 1.941 0 N-CA-C 122.336 3.937 . . . . 0.0 122.336 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.74 -42.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.43 -36.54 84.08 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.2 m -71.34 -49.72 39.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.801 1.241 . . . . 0.0 113.966 170.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.02 85.85 58.82 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.39 124.08 5.74 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.756 2.304 . . . . 0.0 112.975 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.469 0 O-C-N 120.005 -1.684 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.284 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.44 -79.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.606 0 C-N-CA 124.976 3.784 . . . . 0.0 114.254 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -134.67 -71.36 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.51 0.724 . . . . 0.0 111.341 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.15 68.05 1.17 Allowed Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.4 t -160.07 90.44 0.9 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.415 30.3 p90 55.01 11.69 0.53 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -129.49 150.18 74.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 119.824 1.193 . . . . 0.0 113.504 -169.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.15 99.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.332 2.688 . . . . 0.0 111.828 142.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.2 p -74.73 12.9 0.72 Allowed 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -66.23 -26.76 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 153.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.4 p -108.37 58.0 0.61 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 123.208 1.48 . . . . 0.0 114.009 153.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.96 165.41 1.79 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 145.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -114.14 12.09 2.09 Favored 'Cis proline' 0 CA--C 1.56 1.782 0 N-CA-C 119.839 2.977 . . . . 0.0 119.839 8.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 162.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 65.97 59.57 0.7 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.592 1.157 . . . . 0.0 108.258 -166.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.87 143.1 29.6 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.635 -146.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -50.43 -13.69 0.83 Allowed 'Trans proline' 0 CA--C 1.568 2.187 0 N-CA-C 120.964 3.409 . . . . 0.0 120.964 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 m -100.07 -29.9 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 160.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.8 m -74.45 -51.16 15.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.238 1.415 . . . . 0.0 113.843 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.12 84.74 58.94 Favored Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -166.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.22 125.41 6.42 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.567 2.178 . . . . 0.0 113.207 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.58 160.58 16.81 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 C-N-CA 124.413 3.409 . . . . 0.0 114.424 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.4 -37.29 12.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.62 -84.06 1.6 Allowed Glycine 0 CA--C 1.538 1.528 0 N-CA-C 114.434 0.533 . . . . 0.0 114.434 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.4 m -83.49 -40.11 19.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -162.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.309 0.6 OUTLIER -83.78 -8.95 59.12 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.55 149.95 25.43 Favored Pre-proline 0 N--CA 1.486 1.326 0 CA-C-N 120.058 1.299 . . . . 0.0 111.385 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -54.84 99.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.328 2.686 . . . . 0.0 112.229 149.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -87.84 23.2 2.09 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -39.72 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.392 -0.817 . . . . 0.0 111.736 147.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.5 t -73.82 17.69 0.16 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 162.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.58 165.75 0.21 Allowed Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 164.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -110.3 7.1 4.45 Favored 'Cis proline' 0 C--N 1.372 1.785 0 N-CA-C 120.698 3.307 . . . . 0.0 120.698 7.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.03 -25.16 62.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 166.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.27 53.24 5.45 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -93.42 155.49 40.79 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.264 -151.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.55 -14.22 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 N-CA-C 122.442 3.978 . . . . 0.0 122.442 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.23 -29.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.67 -46.61 86.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.624 1.556 . . . . 0.0 114.068 154.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m -86.11 150.22 24.58 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.755 1.622 . . . . 0.0 110.784 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.347 19.9 p90 51.41 73.38 0.98 Allowed Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 166.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.98 123.78 5.85 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.805 2.337 . . . . 0.0 112.741 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 O-C-N 119.96 -1.712 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.562 1.89 0 N-CA-C 114.923 1.086 . . . . 0.0 114.923 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 13.4 m -75.75 -45.01 38.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.77 -75.51 1.96 Allowed Glycine 0 CA--C 1.539 1.587 0 O-C-N 124.053 0.846 . . . . 0.0 112.415 -162.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -134.47 -33.72 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.333 1.4 p90 -69.9 -21.59 63.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -171.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 54.5 m -149.58 153.14 36.39 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 119.781 1.173 . . . . 0.0 111.703 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -56.91 108.34 0.34 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.391 2.727 . . . . 0.0 112.344 157.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.579 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 27.9 p -81.96 17.47 1.56 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 175.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.71 -29.5 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 148.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -71.35 0.87 7.13 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 153.86 15.01 Favored Pre-proline 0 CA--C 1.566 1.567 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -113.29 27.45 1.86 Allowed 'Cis proline' 0 C--N 1.367 1.541 0 N-CA-C 119.471 2.835 . . . . 0.0 119.471 10.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.24 81.5 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 161.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.8 m 56.28 61.79 2.59 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 124.038 0.935 . . . . 0.0 110.711 -162.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -94.61 137.99 22.4 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 115.73 -2.081 . . . . 0.0 113.064 -148.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.99 -27.25 0.88 Allowed 'Trans proline' 0 CA--C 1.562 1.887 0 N-CA-C 121.602 3.655 . . . . 0.0 121.602 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.277 31.5 m -73.25 -40.68 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 167.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.8 t -72.25 -30.11 64.57 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 3.8 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.562 1.878 0 N-CA-C 114.788 1.034 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 18.2 m -78.38 -45.5 22.28 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -167.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.19 -75.41 1.9 Allowed Glycine 0 CA--C 1.543 1.807 0 O-C-N 123.924 0.765 . . . . 0.0 111.957 -159.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.8 m -139.08 -34.17 0.6 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.336 1.9 p90 -65.98 -27.49 68.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -135.32 155.4 78.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 123.78 0.832 . . . . 0.0 111.052 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.36 110.91 0.47 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.121 2.548 . . . . 0.0 112.814 144.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.509 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 57.0 p -79.13 20.57 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 173.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.06 -33.88 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 151.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.26 6.46 1.32 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 162.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.68 151.78 70.24 Favored Pre-proline 0 CA--C 1.567 1.619 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -108.75 25.57 5.47 Favored 'Cis proline' 0 C--N 1.367 1.545 0 N-CA-C 118.822 2.585 . . . . 0.0 118.822 9.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.67 87.91 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 158.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m 54.42 59.87 3.9 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.746 0.818 . . . . 0.0 111.374 -160.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -84.07 151.27 60.02 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -146.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.89 -16.79 0.22 Allowed 'Trans proline' 0 CA--C 1.564 2.013 0 N-CA-C 120.889 3.38 . . . . 0.0 120.889 165.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.51 -48.2 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.17 -28.14 66.14 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.4 m . . . . . 0 CA--C 1.56 1.343 0 C-N-CA 124.358 1.063 . . . . 0.0 113.137 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 CA--C 1.559 1.735 0 N-CA-C 114.422 0.893 . . . . 0.0 114.422 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.6 m -85.72 -44.35 12.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.63 -84.23 1.59 Allowed Glycine 0 CA--C 1.537 1.433 0 O-C-N 123.697 0.623 . . . . 0.0 114.144 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -83.55 -38.13 22.1 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.314 0.4 OUTLIER -83.23 -13.41 55.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 176.607 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -154.76 152.99 26.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 120.485 1.493 . . . . 0.0 112.189 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -51.62 102.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.645 2.897 . . . . 0.0 113.042 148.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -83.27 26.34 0.65 Allowed 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.86 -34.38 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 148.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.3 m -68.07 4.69 1.13 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 162.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.84 152.07 50.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -108.28 22.28 6.38 Favored 'Cis proline' 0 C--N 1.367 1.528 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 7.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.39 98.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 162.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 m 56.64 57.54 4.73 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.013 1.325 . . . . 0.0 110.926 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.08 148.6 45.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 116.708 -1.615 . . . . 0.0 113.494 -146.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.68 -13.69 0.09 OUTLIER 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 121.359 3.561 . . . . 0.0 121.359 169.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.265 59.1 t -88.96 -39.88 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.56 -35.37 78.9 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.666 1.575 . . . . 0.0 115.054 163.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.564 2.009 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 35.4 m -80.24 -50.41 10.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.83 -87.86 1.56 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.278 -165.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -95.42 -55.24 3.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' O ' ' SG ' ' A' ' 31' ' ' CYS 0.335 0.8 OUTLIER -82.6 2.96 30.72 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -158.71 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -164.67 154.61 12.21 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 120.247 1.385 . . . . 0.0 113.052 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.39 108.79 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.63 2.887 . . . . 0.0 113.183 148.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.485 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 47.5 p -82.24 21.1 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.3 -33.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 151.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 m -72.67 8.59 1.39 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 162.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.23 150.62 71.0 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -108.54 23.57 5.97 Favored 'Cis proline' 0 C--N 1.365 1.439 0 N-CA-C 119.067 2.68 . . . . 0.0 119.067 8.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.77 92.23 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 163.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.3 m 56.83 56.35 5.5 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.411 1.084 . . . . 0.0 111.565 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.49 139.74 31.77 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 116.334 -1.793 . . . . 0.0 112.455 -144.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 -24.45 0.25 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 N-CA-C 120.838 3.361 . . . . 0.0 120.838 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.283 6.5 p -72.25 -44.66 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 168.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.7 m -70.77 -29.56 65.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 165.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 CA--C 1.558 1.713 0 N-CA-C 114.501 0.923 . . . . 0.0 114.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.13 -38.49 14.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 -78.16 1.99 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -79.8 -39.31 31.09 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.644 2.461 . . . . 0.0 117.644 -164.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE1' ' SG ' ' A' ' 26' ' ' CYS 0.335 0.5 OUTLIER -86.31 -10.55 54.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 174.335 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -147.27 151.38 40.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 CA-C-N 120.729 1.604 . . . . 0.0 111.771 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 24.2 Cg_exo -57.9 88.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.421 2.747 . . . . 0.0 112.142 148.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 32.59 0.57 Allowed 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.77 -34.46 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.416 -0.802 . . . . 0.0 112.599 148.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 19' ' ' PRO . 17.9 p -68.3 8.22 0.48 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 162.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.44 156.57 0.33 Allowed Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -113.51 19.15 1.99 Allowed 'Cis proline' 0 C--N 1.37 1.661 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 11.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.48 -37.47 82.93 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 161.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 17' ' ' TYR 0.293 14.2 p 49.56 57.05 6.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.528 1.531 . . . . 0.0 112.139 -166.527 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -86.07 148.69 48.46 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 116.813 -1.565 . . . . 0.0 113.678 -150.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.49 -12.54 0.19 Allowed 'Trans proline' 0 CA--C 1.564 1.991 0 N-CA-C 121.856 3.752 . . . . 0.0 121.856 171.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -96.97 -33.47 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 167.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.68 -38.77 86.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 160.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.8 m . . . . . 0 CA--C 1.557 1.242 0 C-N-CA 125.043 1.337 . . . . 0.0 113.746 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.559 1.766 0 N-CA-C 114.536 0.937 . . . . 0.0 114.536 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -85.8 -48.96 8.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 37.27 49.22 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 121.227 3.251 . . . . 0.0 121.227 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 t -162.43 -50.07 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.416 0.686 . . . . 0.0 112.357 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.27 1.4 p90 -96.28 1.9 52.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.35 150.54 14.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 120.718 1.599 . . . . 0.0 111.458 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.34 100.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.441 2.761 . . . . 0.0 112.665 148.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.9 p -86.93 23.39 1.76 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.71 -35.03 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 144.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 33.6 t -79.46 25.04 0.33 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 162.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 161.99 38.48 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -110.72 18.92 3.72 Favored 'Cis proline' 0 C--N 1.369 1.606 0 N-CA-C 119.39 2.804 . . . . 0.0 119.39 6.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.54 90.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 161.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.6 m 57.58 55.59 5.52 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.854 1.262 . . . . 0.0 111.035 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.502 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -88.96 140.17 29.14 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 115.759 -2.067 . . . . 0.0 112.168 -149.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -36.72 -31.86 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.116 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.261 7.0 p -74.21 -41.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.22 -35.07 79.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 160.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 9.8 m . . . . . 0 CA--C 1.575 1.926 0 C-N-CA 125.318 1.447 . . . . 0.0 113.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 0 CA--C 1.561 1.828 0 N-CA-C 114.558 0.946 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -90.31 -44.61 9.58 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.25 -77.83 1.99 Allowed Glycine 0 CA--C 1.539 1.551 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.5 t -74.34 -46.62 39.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.294 0.5 OUTLIER -87.01 -5.34 59.11 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 176.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -153.37 144.58 16.26 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-N 120.009 1.277 . . . . 0.0 110.764 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.35 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.567 2.845 . . . . 0.0 111.867 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.7 m -94.1 35.25 1.18 Allowed 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.406 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.6 t -76.33 -39.85 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.51 -0.744 . . . . 0.0 111.671 142.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.33 14.13 0.1 Allowed 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 161.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.18 165.85 0.07 OUTLIER Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 120.244 3.424 . . . . 0.0 120.244 163.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -108.33 4.54 6.29 Favored 'Cis proline' 0 C--N 1.373 1.834 0 N-CA-C 120.626 3.279 . . . . 0.0 120.626 7.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.34 -22.2 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 168.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.73 51.78 5.98 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.483 1.113 . . . . 0.0 112.288 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.15 156.05 49.08 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 117.088 -1.434 . . . . 0.0 114.339 -151.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.69 2.89 0.46 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 N-CA-C 119.658 2.907 . . . . 0.0 119.658 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -106.32 -27.07 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 161.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.5 m -60.09 -45.69 92.11 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.206 1.366 . . . . 0.0 114.05 155.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m . . . . . 0 N--CA 1.486 1.375 0 C-N-CA 125.27 1.428 . . . . 0.0 113.643 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.558 1.679 0 N-CA-C 115.056 1.137 . . . . 0.0 115.056 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 4.7 p -79.95 -55.11 5.2 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.08 -81.84 1.39 Allowed Glycine 0 CA--C 1.54 1.647 0 O-C-N 123.625 0.578 . . . . 0.0 114.039 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -83.13 -39.45 21.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.919 2.562 . . . . 0.0 117.919 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.321 0.9 OUTLIER -76.74 -21.89 54.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 174.587 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 76.8 m -153.8 148.5 19.6 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-N 119.109 0.868 . . . . 0.0 111.434 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.81 107.58 0.19 Allowed 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 123.983 3.122 . . . . 0.0 113.488 155.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.58 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.3 p -90.97 36.72 0.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.3 -40.96 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.478 155.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.1 15.07 0.12 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.436 2.754 . . . . 0.0 118.436 162.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.22 151.02 7.55 Favored Pre-proline 0 CA--C 1.565 1.539 0 N-CA-C 118.615 2.821 . . . . 0.0 118.615 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -98.68 15.4 28.79 Favored 'Cis proline' 0 N--CA 1.494 1.515 0 N-CA-C 118.982 2.647 . . . . 0.0 118.982 3.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.33 82.27 1.82 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.577 1.656 . . . . 0.0 107.609 159.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.5 m 27.24 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 120.269 3.433 . . . . 0.0 120.269 71.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -106.65 154.16 40.21 Favored Pre-proline 0 N--CA 1.482 1.159 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.319 -159.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 -19.03 0.4 Allowed 'Trans proline' 0 CA--C 1.563 1.941 0 N-CA-C 122.336 3.937 . . . . 0.0 122.336 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.74 -42.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.43 -36.54 84.08 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.2 m . . . . . 0 N--CA 1.486 1.362 0 C-N-CA 124.801 1.241 . . . . 0.0 113.966 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.556 1.606 0 N-CA-C 114.254 0.828 . . . . 0.0 114.254 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -134.67 -71.36 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.51 0.724 . . . . 0.0 111.341 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.15 68.05 1.17 Allowed Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.4 t -160.07 90.44 0.9 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.415 30.3 p90 55.01 11.69 0.53 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -129.49 150.18 74.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 119.824 1.193 . . . . 0.0 113.504 -169.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.15 99.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.332 2.688 . . . . 0.0 111.828 142.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.2 p -74.73 12.9 0.72 Allowed 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -66.23 -26.76 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 153.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.4 p -108.37 58.0 0.61 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 123.208 1.48 . . . . 0.0 114.009 153.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.96 165.41 1.79 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 145.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -114.14 12.09 2.09 Favored 'Cis proline' 0 CA--C 1.56 1.782 0 N-CA-C 119.839 2.977 . . . . 0.0 119.839 8.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 162.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 65.97 59.57 0.7 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.592 1.157 . . . . 0.0 108.258 -166.239 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.87 143.1 29.6 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.635 -146.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -50.43 -13.69 0.83 Allowed 'Trans proline' 0 CA--C 1.568 2.187 0 N-CA-C 120.964 3.409 . . . . 0.0 120.964 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 m -100.07 -29.9 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 160.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.8 m . . . . . 0 CA--C 1.556 1.21 0 C-N-CA 125.238 1.415 . . . . 0.0 113.843 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo . . . . . 0 CA--C 1.558 1.681 0 N-CA-C 114.424 0.894 . . . . 0.0 114.424 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.4 -37.29 12.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.62 -84.06 1.6 Allowed Glycine 0 CA--C 1.538 1.528 0 N-CA-C 114.434 0.533 . . . . 0.0 114.434 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.4 m -83.49 -40.11 19.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -162.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.309 0.6 OUTLIER -83.78 -8.95 59.12 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.55 149.95 25.43 Favored Pre-proline 0 N--CA 1.486 1.326 0 CA-C-N 120.058 1.299 . . . . 0.0 111.385 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -54.84 99.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.328 2.686 . . . . 0.0 112.229 149.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -87.84 23.2 2.09 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -39.72 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.392 -0.817 . . . . 0.0 111.736 147.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.5 t -73.82 17.69 0.16 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 162.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.58 165.75 0.21 Allowed Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 164.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -110.3 7.1 4.45 Favored 'Cis proline' 0 C--N 1.372 1.785 0 N-CA-C 120.698 3.307 . . . . 0.0 120.698 7.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.03 -25.16 62.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 166.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.27 53.24 5.45 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -93.42 155.49 40.79 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.264 -151.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.55 -14.22 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 N-CA-C 122.442 3.978 . . . . 0.0 122.442 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.23 -29.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.67 -46.61 86.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.624 1.556 . . . . 0.0 114.068 154.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 125.755 1.622 . . . . 0.0 110.784 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.255 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.82 174.1 13.3 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 124.735 3.624 . . . . 0.0 114.923 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 13.4 m -75.75 -45.01 38.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.77 -75.51 1.96 Allowed Glycine 0 CA--C 1.539 1.587 0 O-C-N 124.053 0.846 . . . . 0.0 112.415 -162.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -134.47 -33.72 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.333 1.4 p90 -69.9 -21.59 63.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -171.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 54.5 m -149.58 153.14 36.39 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 119.781 1.173 . . . . 0.0 111.703 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -56.91 108.34 0.34 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.391 2.727 . . . . 0.0 112.344 157.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.579 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 27.9 p -81.96 17.47 1.56 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 175.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.71 -29.5 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 148.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -71.35 0.87 7.13 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 153.86 15.01 Favored Pre-proline 0 CA--C 1.566 1.567 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -113.29 27.45 1.86 Allowed 'Cis proline' 0 C--N 1.367 1.541 0 N-CA-C 119.471 2.835 . . . . 0.0 119.471 10.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.24 81.5 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 161.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.8 m 56.28 61.79 2.59 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 124.038 0.935 . . . . 0.0 110.711 -162.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -94.61 137.99 22.4 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 115.73 -2.081 . . . . 0.0 113.064 -148.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.99 -27.25 0.88 Allowed 'Trans proline' 0 CA--C 1.562 1.887 0 N-CA-C 121.602 3.655 . . . . 0.0 121.602 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.277 31.5 m -73.25 -40.68 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 167.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.8 t -72.25 -30.11 64.57 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 3.8 m -72.11 -46.45 56.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -122.13 88.54 48.32 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -161.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.35 123.85 6.23 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.75 2.3 . . . . 0.0 112.949 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.395 0 O-C-N 119.903 -1.748 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.46 177.56 8.5 Favored 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 124.635 3.557 . . . . 0.0 114.788 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 18.2 m -78.38 -45.5 22.28 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -167.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.19 -75.41 1.9 Allowed Glycine 0 CA--C 1.543 1.807 0 O-C-N 123.924 0.765 . . . . 0.0 111.957 -159.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.8 m -139.08 -34.17 0.6 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.336 1.9 p90 -65.98 -27.49 68.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -135.32 155.4 78.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 123.78 0.832 . . . . 0.0 111.052 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.36 110.91 0.47 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.121 2.548 . . . . 0.0 112.814 144.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.509 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 57.0 p -79.13 20.57 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 173.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.06 -33.88 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 151.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.26 6.46 1.32 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 162.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.68 151.78 70.24 Favored Pre-proline 0 CA--C 1.567 1.619 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -108.75 25.57 5.47 Favored 'Cis proline' 0 C--N 1.367 1.545 0 N-CA-C 118.822 2.585 . . . . 0.0 118.822 9.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.67 87.91 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 158.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m 54.42 59.87 3.9 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.746 0.818 . . . . 0.0 111.374 -160.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -84.07 151.27 60.02 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -146.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.89 -16.79 0.22 Allowed 'Trans proline' 0 CA--C 1.564 2.013 0 N-CA-C 120.889 3.38 . . . . 0.0 120.889 165.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.51 -48.2 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.17 -28.14 66.14 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.4 m -73.87 -47.81 35.52 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.358 1.063 . . . . 0.0 113.137 173.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -126.91 85.68 60.45 Favored Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -169.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.15 121.58 4.45 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.715 2.277 . . . . 0.0 112.88 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 O-C-N 119.913 -1.742 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.43 162.51 19.58 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 124.586 3.524 . . . . 0.0 114.422 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.6 m -85.72 -44.35 12.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.63 -84.23 1.59 Allowed Glycine 0 CA--C 1.537 1.433 0 O-C-N 123.697 0.623 . . . . 0.0 114.144 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -83.55 -38.13 22.1 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.314 0.4 OUTLIER -83.23 -13.41 55.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 176.607 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -154.76 152.99 26.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 120.485 1.493 . . . . 0.0 112.189 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -51.62 102.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.645 2.897 . . . . 0.0 113.042 148.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -83.27 26.34 0.65 Allowed 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.86 -34.38 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 148.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.3 m -68.07 4.69 1.13 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 162.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.84 152.07 50.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -108.28 22.28 6.38 Favored 'Cis proline' 0 C--N 1.367 1.528 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 7.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.39 98.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 162.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 m 56.64 57.54 4.73 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.013 1.325 . . . . 0.0 110.926 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.08 148.6 45.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 116.708 -1.615 . . . . 0.0 113.494 -146.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.68 -13.69 0.09 OUTLIER 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 121.359 3.561 . . . . 0.0 121.359 169.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.265 59.1 t -88.96 -39.88 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.56 -35.37 78.9 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.666 1.575 . . . . 0.0 115.054 163.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m -71.45 -47.01 58.44 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -125.86 87.16 56.45 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.35 122.07 4.5 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.521 2.147 . . . . 0.0 112.946 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.438 0 O-C-N 119.918 -1.739 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.79 -178.42 4.59 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 124.584 3.523 . . . . 0.0 114.869 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 35.4 m -80.24 -50.41 10.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.83 -87.86 1.56 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.278 -165.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -95.42 -55.24 3.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' O ' ' SG ' ' A' ' 31' ' ' CYS 0.335 0.8 OUTLIER -82.6 2.96 30.72 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -158.71 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -164.67 154.61 12.21 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 120.247 1.385 . . . . 0.0 113.052 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.39 108.79 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.63 2.887 . . . . 0.0 113.183 148.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.485 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 47.5 p -82.24 21.1 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.3 -33.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 151.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 m -72.67 8.59 1.39 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 162.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.23 150.62 71.0 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -108.54 23.57 5.97 Favored 'Cis proline' 0 C--N 1.365 1.439 0 N-CA-C 119.067 2.68 . . . . 0.0 119.067 8.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.77 92.23 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 163.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.3 m 56.83 56.35 5.5 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.411 1.084 . . . . 0.0 111.565 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.49 139.74 31.77 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 116.334 -1.793 . . . . 0.0 112.455 -144.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 -24.45 0.25 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 N-CA-C 120.838 3.361 . . . . 0.0 120.838 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.283 6.5 p -72.25 -44.66 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 168.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.7 m -70.77 -29.56 65.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 165.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m -73.25 -45.9 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -121.92 89.26 48.12 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -163.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.85 123.39 5.76 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.816 2.344 . . . . 0.0 113.027 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 119.944 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.29 158.6 29.69 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 124.541 3.494 . . . . 0.0 114.501 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.13 -38.49 14.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 -78.16 1.99 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -79.8 -39.31 31.09 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.644 2.461 . . . . 0.0 117.644 -164.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE1' ' SG ' ' A' ' 26' ' ' CYS 0.335 0.5 OUTLIER -86.31 -10.55 54.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 174.335 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -147.27 151.38 40.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 CA-C-N 120.729 1.604 . . . . 0.0 111.771 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 24.2 Cg_exo -57.9 88.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.421 2.747 . . . . 0.0 112.142 148.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 32.59 0.57 Allowed 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.77 -34.46 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.416 -0.802 . . . . 0.0 112.599 148.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 19' ' ' PRO . 17.9 p -68.3 8.22 0.48 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 162.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.44 156.57 0.33 Allowed Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -113.51 19.15 1.99 Allowed 'Cis proline' 0 C--N 1.37 1.661 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 11.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.48 -37.47 82.93 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 161.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 17' ' ' TYR 0.293 14.2 p 49.56 57.05 6.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.528 1.531 . . . . 0.0 112.139 -166.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -86.07 148.69 48.46 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 116.813 -1.565 . . . . 0.0 113.678 -150.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.49 -12.54 0.19 Allowed 'Trans proline' 0 CA--C 1.564 1.991 0 N-CA-C 121.856 3.752 . . . . 0.0 121.856 171.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -96.97 -33.47 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 167.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.68 -38.77 86.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 160.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.8 m -73.46 -52.01 15.18 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.043 1.337 . . . . 0.0 113.746 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -126.58 83.52 64.61 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 123.15 5.49 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.794 2.329 . . . . 0.0 113.038 -171.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.444 0 O-C-N 119.834 -1.791 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.13 160.94 18.0 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 124.574 3.516 . . . . 0.0 114.536 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -85.8 -48.96 8.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 37.27 49.22 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 121.227 3.251 . . . . 0.0 121.227 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 t -162.43 -50.07 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.416 0.686 . . . . 0.0 112.357 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.27 1.4 p90 -96.28 1.9 52.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.35 150.54 14.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 120.718 1.599 . . . . 0.0 111.458 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.34 100.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.441 2.761 . . . . 0.0 112.665 148.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.9 p -86.93 23.39 1.76 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.71 -35.03 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 144.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 33.6 t -79.46 25.04 0.33 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 162.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 161.99 38.48 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -110.72 18.92 3.72 Favored 'Cis proline' 0 C--N 1.369 1.606 0 N-CA-C 119.39 2.804 . . . . 0.0 119.39 6.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.54 90.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 161.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.6 m 57.58 55.59 5.52 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.854 1.262 . . . . 0.0 111.035 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.502 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -88.96 140.17 29.14 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 115.759 -2.067 . . . . 0.0 112.168 -149.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -36.72 -31.86 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.116 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.261 7.0 p -74.21 -41.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.22 -35.07 79.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 160.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 9.8 m -73.45 171.05 13.84 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 125.318 1.447 . . . . 0.0 113.205 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -127.4 130.69 23.67 Favored Pre-proline 0 CA--C 1.566 1.588 1 O-C-N 114.582 -5.074 . . . . 0.0 109.586 11.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 124.44 6.2 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.986 2.457 . . . . 0.0 112.978 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 O-C-N 119.968 -1.708 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -83.29 164.05 14.92 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 124.618 3.545 . . . . 0.0 114.558 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -90.31 -44.61 9.58 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.25 -77.83 1.99 Allowed Glycine 0 CA--C 1.539 1.551 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.5 t -74.34 -46.62 39.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.294 0.5 OUTLIER -87.01 -5.34 59.11 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 176.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -153.37 144.58 16.26 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-N 120.009 1.277 . . . . 0.0 110.764 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.35 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.567 2.845 . . . . 0.0 111.867 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.7 m -94.1 35.25 1.18 Allowed 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.406 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.6 t -76.33 -39.85 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.51 -0.744 . . . . 0.0 111.671 142.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.33 14.13 0.1 Allowed 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 161.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.18 165.85 0.07 OUTLIER Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 120.244 3.424 . . . . 0.0 120.244 163.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -108.33 4.54 6.29 Favored 'Cis proline' 0 C--N 1.373 1.834 0 N-CA-C 120.626 3.279 . . . . 0.0 120.626 7.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.34 -22.2 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 168.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.73 51.78 5.98 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.483 1.113 . . . . 0.0 112.288 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.15 156.05 49.08 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 117.088 -1.434 . . . . 0.0 114.339 -151.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.69 2.89 0.46 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 N-CA-C 119.658 2.907 . . . . 0.0 119.658 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -106.32 -27.07 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 161.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.5 m -60.09 -45.69 92.11 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.206 1.366 . . . . 0.0 114.05 155.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m -77.41 -47.18 20.45 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.27 1.428 . . . . 0.0 113.643 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -124.6 82.81 58.94 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.06 -61.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.559 1.771 0 C-N-CA 122.816 2.344 . . . . 0.0 115.087 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.232 0 O-C-N 119.018 -2.301 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.322 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 168.48 24.7 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 124.647 3.565 . . . . 0.0 115.056 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 4.7 p -79.95 -55.11 5.2 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.08 -81.84 1.39 Allowed Glycine 0 CA--C 1.54 1.647 0 O-C-N 123.625 0.578 . . . . 0.0 114.039 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -83.13 -39.45 21.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.919 2.562 . . . . 0.0 117.919 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.321 0.9 OUTLIER -76.74 -21.89 54.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 174.587 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 76.8 m -153.8 148.5 19.6 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-N 119.109 0.868 . . . . 0.0 111.434 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.81 107.58 0.19 Allowed 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 123.983 3.122 . . . . 0.0 113.488 155.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.58 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.3 p -90.97 36.72 0.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.3 -40.96 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.478 155.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.1 15.07 0.12 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.436 2.754 . . . . 0.0 118.436 162.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.22 151.02 7.55 Favored Pre-proline 0 CA--C 1.565 1.539 0 N-CA-C 118.615 2.821 . . . . 0.0 118.615 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -98.68 15.4 28.79 Favored 'Cis proline' 0 N--CA 1.494 1.515 0 N-CA-C 118.982 2.647 . . . . 0.0 118.982 3.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.33 82.27 1.82 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.577 1.656 . . . . 0.0 107.609 159.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.5 m 27.24 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 120.269 3.433 . . . . 0.0 120.269 71.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -106.65 154.16 40.21 Favored Pre-proline 0 N--CA 1.482 1.159 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.319 -159.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 -19.03 0.4 Allowed 'Trans proline' 0 CA--C 1.563 1.941 0 N-CA-C 122.336 3.937 . . . . 0.0 122.336 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.74 -42.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.43 -36.54 84.08 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.2 m -71.34 -49.72 39.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.801 1.241 . . . . 0.0 113.966 170.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.02 85.85 58.82 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.39 124.08 5.74 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.756 2.304 . . . . 0.0 112.975 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.469 0 O-C-N 120.005 -1.684 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.284 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.44 -79.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.606 0 C-N-CA 124.976 3.784 . . . . 0.0 114.254 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -134.67 -71.36 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.51 0.724 . . . . 0.0 111.341 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.15 68.05 1.17 Allowed Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.4 t -160.07 90.44 0.9 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.415 30.3 p90 55.01 11.69 0.53 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -129.49 150.18 74.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 119.824 1.193 . . . . 0.0 113.504 -169.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.15 99.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.332 2.688 . . . . 0.0 111.828 142.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.2 p -74.73 12.9 0.72 Allowed 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -66.23 -26.76 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 153.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.4 p -108.37 58.0 0.61 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 123.208 1.48 . . . . 0.0 114.009 153.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.96 165.41 1.79 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 145.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -114.14 12.09 2.09 Favored 'Cis proline' 0 CA--C 1.56 1.782 0 N-CA-C 119.839 2.977 . . . . 0.0 119.839 8.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 162.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 65.97 59.57 0.7 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.592 1.157 . . . . 0.0 108.258 -166.239 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.87 143.1 29.6 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.635 -146.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -50.43 -13.69 0.83 Allowed 'Trans proline' 0 CA--C 1.568 2.187 0 N-CA-C 120.964 3.409 . . . . 0.0 120.964 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 m -100.07 -29.9 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 160.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.8 m -74.45 -51.16 15.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.238 1.415 . . . . 0.0 113.843 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.12 84.74 58.94 Favored Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -166.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.22 125.41 6.42 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.567 2.178 . . . . 0.0 113.207 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.58 160.58 16.81 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 C-N-CA 124.413 3.409 . . . . 0.0 114.424 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.4 -37.29 12.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.62 -84.06 1.6 Allowed Glycine 0 CA--C 1.538 1.528 0 N-CA-C 114.434 0.533 . . . . 0.0 114.434 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.4 m -83.49 -40.11 19.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -162.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.309 0.6 OUTLIER -83.78 -8.95 59.12 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.55 149.95 25.43 Favored Pre-proline 0 N--CA 1.486 1.326 0 CA-C-N 120.058 1.299 . . . . 0.0 111.385 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -54.84 99.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.328 2.686 . . . . 0.0 112.229 149.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -87.84 23.2 2.09 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -39.72 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.392 -0.817 . . . . 0.0 111.736 147.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.5 t -73.82 17.69 0.16 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 162.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.58 165.75 0.21 Allowed Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 164.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -110.3 7.1 4.45 Favored 'Cis proline' 0 C--N 1.372 1.785 0 N-CA-C 120.698 3.307 . . . . 0.0 120.698 7.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.03 -25.16 62.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 166.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.27 53.24 5.45 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -93.42 155.49 40.79 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.264 -151.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.55 -14.22 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 N-CA-C 122.442 3.978 . . . . 0.0 122.442 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.23 -29.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.67 -46.61 86.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.624 1.556 . . . . 0.0 114.068 154.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m -86.11 150.22 24.58 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.755 1.622 . . . . 0.0 110.784 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.347 19.9 p90 51.41 73.38 0.98 Allowed Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 166.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.98 123.78 5.85 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.805 2.337 . . . . 0.0 112.741 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 O-C-N 119.96 -1.712 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo . . . . . 0 CA--C 1.562 1.89 0 N-CA-C 114.923 1.086 . . . . 0.0 114.923 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 13.4 m -75.75 -45.01 38.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.77 -75.51 1.96 Allowed Glycine 0 CA--C 1.539 1.587 0 O-C-N 124.053 0.846 . . . . 0.0 112.415 -162.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -134.47 -33.72 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.333 1.4 p90 -69.9 -21.59 63.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -171.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 54.5 m -149.58 153.14 36.39 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 119.781 1.173 . . . . 0.0 111.703 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -56.91 108.34 0.34 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.391 2.727 . . . . 0.0 112.344 157.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.579 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 27.9 p -81.96 17.47 1.56 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 175.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.71 -29.5 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 148.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -71.35 0.87 7.13 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 153.86 15.01 Favored Pre-proline 0 CA--C 1.566 1.567 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -113.29 27.45 1.86 Allowed 'Cis proline' 0 C--N 1.367 1.541 0 N-CA-C 119.471 2.835 . . . . 0.0 119.471 10.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.24 81.5 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 161.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.8 m 56.28 61.79 2.59 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 124.038 0.935 . . . . 0.0 110.711 -162.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -94.61 137.99 22.4 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 115.73 -2.081 . . . . 0.0 113.064 -148.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.99 -27.25 0.88 Allowed 'Trans proline' 0 CA--C 1.562 1.887 0 N-CA-C 121.602 3.655 . . . . 0.0 121.602 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.277 31.5 m -73.25 -40.68 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 167.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.8 t -72.25 -30.11 64.57 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 3.8 m . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo . . . . . 0 CA--C 1.562 1.878 0 N-CA-C 114.788 1.034 . . . . 0.0 114.788 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 18.2 m -78.38 -45.5 22.28 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -167.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.19 -75.41 1.9 Allowed Glycine 0 CA--C 1.543 1.807 0 O-C-N 123.924 0.765 . . . . 0.0 111.957 -159.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.8 m -139.08 -34.17 0.6 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.336 1.9 p90 -65.98 -27.49 68.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -135.32 155.4 78.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 123.78 0.832 . . . . 0.0 111.052 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.36 110.91 0.47 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.121 2.548 . . . . 0.0 112.814 144.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.509 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 57.0 p -79.13 20.57 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 173.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.06 -33.88 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 151.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.26 6.46 1.32 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 162.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.68 151.78 70.24 Favored Pre-proline 0 CA--C 1.567 1.619 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -108.75 25.57 5.47 Favored 'Cis proline' 0 C--N 1.367 1.545 0 N-CA-C 118.822 2.585 . . . . 0.0 118.822 9.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.67 87.91 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 158.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m 54.42 59.87 3.9 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.746 0.818 . . . . 0.0 111.374 -160.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -84.07 151.27 60.02 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -146.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.89 -16.79 0.22 Allowed 'Trans proline' 0 CA--C 1.564 2.013 0 N-CA-C 120.889 3.38 . . . . 0.0 120.889 165.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.51 -48.2 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.17 -28.14 66.14 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.4 m . . . . . 0 CA--C 1.56 1.343 0 C-N-CA 124.358 1.063 . . . . 0.0 113.137 173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo . . . . . 0 CA--C 1.559 1.735 0 N-CA-C 114.422 0.893 . . . . 0.0 114.422 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.6 m -85.72 -44.35 12.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.63 -84.23 1.59 Allowed Glycine 0 CA--C 1.537 1.433 0 O-C-N 123.697 0.623 . . . . 0.0 114.144 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -83.55 -38.13 22.1 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.314 0.4 OUTLIER -83.23 -13.41 55.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 176.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -154.76 152.99 26.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 120.485 1.493 . . . . 0.0 112.189 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -51.62 102.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.645 2.897 . . . . 0.0 113.042 148.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -83.27 26.34 0.65 Allowed 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.86 -34.38 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 148.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.3 m -68.07 4.69 1.13 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 162.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.84 152.07 50.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -108.28 22.28 6.38 Favored 'Cis proline' 0 C--N 1.367 1.528 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 7.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.39 98.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 162.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 m 56.64 57.54 4.73 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.013 1.325 . . . . 0.0 110.926 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.08 148.6 45.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 116.708 -1.615 . . . . 0.0 113.494 -146.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.68 -13.69 0.09 OUTLIER 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 121.359 3.561 . . . . 0.0 121.359 169.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.265 59.1 t -88.96 -39.88 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.56 -35.37 78.9 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.666 1.575 . . . . 0.0 115.054 163.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.564 2.009 0 N-CA-C 114.869 1.065 . . . . 0.0 114.869 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 35.4 m -80.24 -50.41 10.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.83 -87.86 1.56 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.278 -165.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -95.42 -55.24 3.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' O ' ' SG ' ' A' ' 31' ' ' CYS 0.335 0.8 OUTLIER -82.6 2.96 30.72 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -158.71 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -164.67 154.61 12.21 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 120.247 1.385 . . . . 0.0 113.052 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.39 108.79 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.63 2.887 . . . . 0.0 113.183 148.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.485 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 47.5 p -82.24 21.1 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.3 -33.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 151.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 m -72.67 8.59 1.39 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 162.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.23 150.62 71.0 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -108.54 23.57 5.97 Favored 'Cis proline' 0 C--N 1.365 1.439 0 N-CA-C 119.067 2.68 . . . . 0.0 119.067 8.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.77 92.23 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 163.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.3 m 56.83 56.35 5.5 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.411 1.084 . . . . 0.0 111.565 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.49 139.74 31.77 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 116.334 -1.793 . . . . 0.0 112.455 -144.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 -24.45 0.25 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 N-CA-C 120.838 3.361 . . . . 0.0 120.838 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.283 6.5 p -72.25 -44.66 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 168.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.7 m -70.77 -29.56 65.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 165.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 CA--C 1.558 1.713 0 N-CA-C 114.501 0.923 . . . . 0.0 114.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.13 -38.49 14.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 -78.16 1.99 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -79.8 -39.31 31.09 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.644 2.461 . . . . 0.0 117.644 -164.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE1' ' SG ' ' A' ' 26' ' ' CYS 0.335 0.5 OUTLIER -86.31 -10.55 54.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 174.335 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -147.27 151.38 40.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 CA-C-N 120.729 1.604 . . . . 0.0 111.771 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 24.2 Cg_exo -57.9 88.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.421 2.747 . . . . 0.0 112.142 148.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 32.59 0.57 Allowed 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.77 -34.46 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.416 -0.802 . . . . 0.0 112.599 148.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 19' ' ' PRO . 17.9 p -68.3 8.22 0.48 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 162.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.44 156.57 0.33 Allowed Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -113.51 19.15 1.99 Allowed 'Cis proline' 0 C--N 1.37 1.661 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 11.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.48 -37.47 82.93 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 161.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 17' ' ' TYR 0.293 14.2 p 49.56 57.05 6.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.528 1.531 . . . . 0.0 112.139 -166.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -86.07 148.69 48.46 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 116.813 -1.565 . . . . 0.0 113.678 -150.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.49 -12.54 0.19 Allowed 'Trans proline' 0 CA--C 1.564 1.991 0 N-CA-C 121.856 3.752 . . . . 0.0 121.856 171.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -96.97 -33.47 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 167.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.68 -38.77 86.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 160.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.8 m . . . . . 0 CA--C 1.557 1.242 0 C-N-CA 125.043 1.337 . . . . 0.0 113.746 173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.559 1.766 0 N-CA-C 114.536 0.937 . . . . 0.0 114.536 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -85.8 -48.96 8.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 37.27 49.22 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 121.227 3.251 . . . . 0.0 121.227 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 t -162.43 -50.07 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.416 0.686 . . . . 0.0 112.357 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.27 1.4 p90 -96.28 1.9 52.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.35 150.54 14.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 120.718 1.599 . . . . 0.0 111.458 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.34 100.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.441 2.761 . . . . 0.0 112.665 148.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.9 p -86.93 23.39 1.76 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.71 -35.03 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 144.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 33.6 t -79.46 25.04 0.33 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 162.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 161.99 38.48 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -110.72 18.92 3.72 Favored 'Cis proline' 0 C--N 1.369 1.606 0 N-CA-C 119.39 2.804 . . . . 0.0 119.39 6.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.54 90.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 161.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.6 m 57.58 55.59 5.52 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.854 1.262 . . . . 0.0 111.035 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.502 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -88.96 140.17 29.14 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 115.759 -2.067 . . . . 0.0 112.168 -149.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -36.72 -31.86 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.116 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.261 7.0 p -74.21 -41.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.22 -35.07 79.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 160.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 9.8 m . . . . . 0 CA--C 1.575 1.926 0 C-N-CA 125.318 1.447 . . . . 0.0 113.205 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 0 CA--C 1.561 1.828 0 N-CA-C 114.558 0.946 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -90.31 -44.61 9.58 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.25 -77.83 1.99 Allowed Glycine 0 CA--C 1.539 1.551 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.5 t -74.34 -46.62 39.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.294 0.5 OUTLIER -87.01 -5.34 59.11 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 176.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -153.37 144.58 16.26 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-N 120.009 1.277 . . . . 0.0 110.764 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.35 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.567 2.845 . . . . 0.0 111.867 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.7 m -94.1 35.25 1.18 Allowed 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.406 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.6 t -76.33 -39.85 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.51 -0.744 . . . . 0.0 111.671 142.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.33 14.13 0.1 Allowed 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 161.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.18 165.85 0.07 OUTLIER Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 120.244 3.424 . . . . 0.0 120.244 163.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -108.33 4.54 6.29 Favored 'Cis proline' 0 C--N 1.373 1.834 0 N-CA-C 120.626 3.279 . . . . 0.0 120.626 7.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.34 -22.2 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 168.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.73 51.78 5.98 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.483 1.113 . . . . 0.0 112.288 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.15 156.05 49.08 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 117.088 -1.434 . . . . 0.0 114.339 -151.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.69 2.89 0.46 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 N-CA-C 119.658 2.907 . . . . 0.0 119.658 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -106.32 -27.07 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 161.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.5 m -60.09 -45.69 92.11 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.206 1.366 . . . . 0.0 114.05 155.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m . . . . . 0 N--CA 1.486 1.375 0 C-N-CA 125.27 1.428 . . . . 0.0 113.643 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo . . . . . 0 CA--C 1.558 1.679 0 N-CA-C 115.056 1.137 . . . . 0.0 115.056 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 4.7 p -79.95 -55.11 5.2 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.08 -81.84 1.39 Allowed Glycine 0 CA--C 1.54 1.647 0 O-C-N 123.625 0.578 . . . . 0.0 114.039 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -83.13 -39.45 21.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.919 2.562 . . . . 0.0 117.919 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.321 0.9 OUTLIER -76.74 -21.89 54.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 174.587 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 76.8 m -153.8 148.5 19.6 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-N 119.109 0.868 . . . . 0.0 111.434 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.81 107.58 0.19 Allowed 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 123.983 3.122 . . . . 0.0 113.488 155.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.58 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.3 p -90.97 36.72 0.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.3 -40.96 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.478 155.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.1 15.07 0.12 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.436 2.754 . . . . 0.0 118.436 162.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.22 151.02 7.55 Favored Pre-proline 0 CA--C 1.565 1.539 0 N-CA-C 118.615 2.821 . . . . 0.0 118.615 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -98.68 15.4 28.79 Favored 'Cis proline' 0 N--CA 1.494 1.515 0 N-CA-C 118.982 2.647 . . . . 0.0 118.982 3.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.33 82.27 1.82 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.577 1.656 . . . . 0.0 107.609 159.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.5 m 27.24 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 120.269 3.433 . . . . 0.0 120.269 71.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -106.65 154.16 40.21 Favored Pre-proline 0 N--CA 1.482 1.159 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.319 -159.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 -19.03 0.4 Allowed 'Trans proline' 0 CA--C 1.563 1.941 0 N-CA-C 122.336 3.937 . . . . 0.0 122.336 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.74 -42.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.43 -36.54 84.08 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.2 m . . . . . 0 N--CA 1.486 1.362 0 C-N-CA 124.801 1.241 . . . . 0.0 113.966 170.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 CA--C 1.556 1.606 0 N-CA-C 114.254 0.828 . . . . 0.0 114.254 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -134.67 -71.36 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.51 0.724 . . . . 0.0 111.341 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.15 68.05 1.17 Allowed Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.4 t -160.07 90.44 0.9 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.415 30.3 p90 55.01 11.69 0.53 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -129.49 150.18 74.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 119.824 1.193 . . . . 0.0 113.504 -169.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.15 99.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.332 2.688 . . . . 0.0 111.828 142.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.2 p -74.73 12.9 0.72 Allowed 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -66.23 -26.76 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 153.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.4 p -108.37 58.0 0.61 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 123.208 1.48 . . . . 0.0 114.009 153.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.96 165.41 1.79 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 145.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -114.14 12.09 2.09 Favored 'Cis proline' 0 CA--C 1.56 1.782 0 N-CA-C 119.839 2.977 . . . . 0.0 119.839 8.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 162.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 65.97 59.57 0.7 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.592 1.157 . . . . 0.0 108.258 -166.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.87 143.1 29.6 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.635 -146.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -50.43 -13.69 0.83 Allowed 'Trans proline' 0 CA--C 1.568 2.187 0 N-CA-C 120.964 3.409 . . . . 0.0 120.964 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 m -100.07 -29.9 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 160.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.8 m . . . . . 0 CA--C 1.556 1.21 0 C-N-CA 125.238 1.415 . . . . 0.0 113.843 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo . . . . . 0 CA--C 1.558 1.681 0 N-CA-C 114.424 0.894 . . . . 0.0 114.424 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.4 -37.29 12.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.62 -84.06 1.6 Allowed Glycine 0 CA--C 1.538 1.528 0 N-CA-C 114.434 0.533 . . . . 0.0 114.434 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.4 m -83.49 -40.11 19.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -162.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.309 0.6 OUTLIER -83.78 -8.95 59.12 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.55 149.95 25.43 Favored Pre-proline 0 N--CA 1.486 1.326 0 CA-C-N 120.058 1.299 . . . . 0.0 111.385 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -54.84 99.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.328 2.686 . . . . 0.0 112.229 149.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -87.84 23.2 2.09 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -39.72 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.392 -0.817 . . . . 0.0 111.736 147.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.5 t -73.82 17.69 0.16 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 162.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.58 165.75 0.21 Allowed Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 164.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -110.3 7.1 4.45 Favored 'Cis proline' 0 C--N 1.372 1.785 0 N-CA-C 120.698 3.307 . . . . 0.0 120.698 7.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.03 -25.16 62.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 166.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.27 53.24 5.45 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -93.42 155.49 40.79 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.264 -151.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.55 -14.22 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 N-CA-C 122.442 3.978 . . . . 0.0 122.442 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.23 -29.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.67 -46.61 86.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.624 1.556 . . . . 0.0 114.068 154.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 125.755 1.622 . . . . 0.0 110.784 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.255 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.82 174.1 13.3 Favored 'Trans proline' 0 CA--C 1.562 1.89 0 C-N-CA 124.735 3.624 . . . . 0.0 114.923 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 13.4 m -75.75 -45.01 38.88 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -169.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.77 -75.51 1.96 Allowed Glycine 0 CA--C 1.539 1.587 0 O-C-N 124.053 0.846 . . . . 0.0 112.415 -162.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.4 m -134.47 -33.72 0.97 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 117.008 2.225 . . . . 0.0 117.008 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.333 1.4 p90 -69.9 -21.59 63.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -171.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 54.5 m -149.58 153.14 36.39 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 119.781 1.173 . . . . 0.0 111.703 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -56.91 108.34 0.34 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.391 2.727 . . . . 0.0 112.344 157.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.579 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 27.9 p -81.96 17.47 1.56 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 175.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 m -69.71 -29.5 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 148.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.5 m -71.35 0.87 7.13 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 161.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.75 153.86 15.01 Favored Pre-proline 0 CA--C 1.566 1.567 0 N-CA-C 117.561 2.43 . . . . 0.0 117.561 -172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -113.29 27.45 1.86 Allowed 'Cis proline' 0 C--N 1.367 1.541 0 N-CA-C 119.471 2.835 . . . . 0.0 119.471 10.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.47 -43.24 81.5 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 161.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.8 m 56.28 61.79 2.59 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 124.038 0.935 . . . . 0.0 110.711 -162.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.488 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -94.61 137.99 22.4 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 115.73 -2.081 . . . . 0.0 113.064 -148.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -42.99 -27.25 0.88 Allowed 'Trans proline' 0 CA--C 1.562 1.887 0 N-CA-C 121.602 3.655 . . . . 0.0 121.602 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.277 31.5 m -73.25 -40.68 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 116.484 2.031 . . . . 0.0 116.484 167.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.8 t -72.25 -30.11 64.57 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 165.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.488 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 3.8 m -72.11 -46.45 56.61 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -122.13 88.54 48.32 Favored Pre-proline 0 CA--C 1.564 1.518 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -161.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.35 123.85 6.23 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.75 2.3 . . . . 0.0 112.949 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.395 0 O-C-N 119.903 -1.748 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.46 177.56 8.5 Favored 'Trans proline' 0 CA--C 1.562 1.878 0 C-N-CA 124.635 3.557 . . . . 0.0 114.788 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 18.2 m -78.38 -45.5 22.28 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -167.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.19 -75.41 1.9 Allowed Glycine 0 CA--C 1.543 1.807 0 O-C-N 123.924 0.765 . . . . 0.0 111.957 -159.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.8 m -139.08 -34.17 0.6 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.336 1.9 p90 -65.98 -27.49 68.18 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -172.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -135.32 155.4 78.74 Favored Pre-proline 0 N--CA 1.491 1.604 0 C-N-CA 123.78 0.832 . . . . 0.0 111.052 177.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.36 110.91 0.47 Allowed 'Trans proline' 0 C--N 1.367 1.517 0 C-N-CA 123.121 2.548 . . . . 0.0 112.814 144.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.509 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 57.0 p -79.13 20.57 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 173.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.06 -33.88 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 151.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.6 m -70.26 6.46 1.32 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.611 2.448 . . . . 0.0 117.611 162.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.68 151.78 70.24 Favored Pre-proline 0 CA--C 1.567 1.619 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -108.75 25.57 5.47 Favored 'Cis proline' 0 C--N 1.367 1.545 0 N-CA-C 118.822 2.585 . . . . 0.0 118.822 9.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.01 -45.67 87.91 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 158.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.9 m 54.42 59.87 3.9 Favored 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.746 0.818 . . . . 0.0 111.374 -160.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -84.07 151.27 60.02 Favored Pre-proline 0 N--CA 1.482 1.174 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -146.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -45.89 -16.79 0.22 Allowed 'Trans proline' 0 CA--C 1.564 2.013 0 N-CA-C 120.889 3.38 . . . . 0.0 120.889 165.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.8 t -83.51 -48.2 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 61.5 m -69.17 -28.14 66.14 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 168.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 56.4 m -73.87 -47.81 35.52 Favored 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.358 1.063 . . . . 0.0 113.137 173.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -126.91 85.68 60.45 Favored Pre-proline 0 CA--C 1.567 1.597 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -169.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.15 121.58 4.45 Favored 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.715 2.277 . . . . 0.0 112.88 -173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 O-C-N 119.913 -1.742 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.316 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.43 162.51 19.58 Favored 'Trans proline' 0 CA--C 1.559 1.735 0 C-N-CA 124.586 3.524 . . . . 0.0 114.422 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.6 m -85.72 -44.35 12.61 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.91 1.818 . . . . 0.0 115.91 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.63 -84.23 1.59 Allowed Glycine 0 CA--C 1.537 1.433 0 O-C-N 123.697 0.623 . . . . 0.0 114.144 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.0 m -83.55 -38.13 22.1 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 -162.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.314 0.4 OUTLIER -83.23 -13.41 55.4 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 176.607 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -154.76 152.99 26.9 Favored Pre-proline 0 N--CA 1.487 1.404 0 CA-C-N 120.485 1.493 . . . . 0.0 112.189 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -51.62 102.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.645 2.897 . . . . 0.0 113.042 148.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.3 p -83.27 26.34 0.65 Allowed 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 116.423 2.008 . . . . 0.0 116.423 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.86 -34.38 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 148.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 39.3 m -68.07 4.69 1.13 Allowed 'General case' 0 CA--C 1.57 1.73 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 162.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.84 152.07 50.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -172.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -108.28 22.28 6.38 Favored 'Cis proline' 0 C--N 1.367 1.528 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 7.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.19 -43.39 98.32 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 162.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 m 56.64 57.54 4.73 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.013 1.325 . . . . 0.0 110.926 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.08 148.6 45.53 Favored Pre-proline 0 N--CA 1.481 1.104 0 CA-C-O 116.708 -1.615 . . . . 0.0 113.494 -146.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.68 -13.69 0.09 OUTLIER 'Trans proline' 0 CA--C 1.564 2.0 0 N-CA-C 121.359 3.561 . . . . 0.0 121.359 169.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.265 59.1 t -88.96 -39.88 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 169.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.6 m -67.56 -35.37 78.9 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 120.666 1.575 . . . . 0.0 115.054 163.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m -71.45 -47.01 58.44 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -125.86 87.16 56.45 Favored Pre-proline 0 CA--C 1.566 1.56 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -171.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.35 122.07 4.5 Favored 'Trans proline' 0 C--N 1.371 1.749 0 C-N-CA 122.521 2.147 . . . . 0.0 112.946 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.438 0 O-C-N 119.918 -1.739 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -77.79 -178.42 4.59 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 124.584 3.523 . . . . 0.0 114.869 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 35.4 m -80.24 -50.41 10.26 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -171.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.83 -87.86 1.56 Allowed Glycine 0 CA--C 1.536 1.382 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.278 -165.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.6 p -95.42 -55.24 3.11 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' O ' ' SG ' ' A' ' 31' ' ' CYS 0.335 0.8 OUTLIER -82.6 2.96 30.72 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -158.71 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.408 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -164.67 154.61 12.21 Favored Pre-proline 0 N--CA 1.493 1.688 0 CA-C-N 120.247 1.385 . . . . 0.0 113.052 179.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -52.39 108.79 0.28 Allowed 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.63 2.887 . . . . 0.0 113.183 148.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.485 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 47.5 p -82.24 21.1 0.95 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.928 2.196 . . . . 0.0 116.928 175.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.3 -33.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 151.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 37.6 m -72.67 8.59 1.39 Allowed 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 117.4 2.37 . . . . 0.0 117.4 162.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.23 150.62 71.0 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 -176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -108.54 23.57 5.97 Favored 'Cis proline' 0 C--N 1.365 1.439 0 N-CA-C 119.067 2.68 . . . . 0.0 119.067 8.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.25 -38.77 92.23 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 163.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 79.3 m 56.83 56.35 5.5 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.411 1.084 . . . . 0.0 111.565 -168.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -87.49 139.74 31.77 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 116.334 -1.793 . . . . 0.0 112.455 -144.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 -24.45 0.25 Allowed 'Trans proline' 0 CA--C 1.56 1.798 0 N-CA-C 120.838 3.361 . . . . 0.0 120.838 169.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.283 6.5 p -72.25 -44.66 63.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 117.147 2.277 . . . . 0.0 117.147 168.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 71.7 m -70.77 -29.56 65.81 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 165.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 4.6 m -73.25 -45.9 53.2 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -121.92 89.26 48.12 Favored Pre-proline 0 CA--C 1.565 1.557 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -163.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.85 123.39 5.76 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.816 2.344 . . . . 0.0 113.027 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 O-C-N 119.944 -1.723 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.267 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -78.29 158.6 29.69 Favored 'Trans proline' 0 CA--C 1.558 1.713 0 C-N-CA 124.541 3.494 . . . . 0.0 114.501 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.2 m -89.13 -38.49 14.28 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.94 -78.16 1.99 Allowed Glycine 0 CA--C 1.54 1.643 0 N-CA-C 114.983 0.753 . . . . 0.0 114.983 -173.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.1 m -79.8 -39.31 31.09 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 117.644 2.461 . . . . 0.0 117.644 -164.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' CE1' ' SG ' ' A' ' 26' ' ' CYS 0.335 0.5 OUTLIER -86.31 -10.55 54.25 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 174.335 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -147.27 151.38 40.37 Favored Pre-proline 0 N--CA 1.488 1.451 0 CA-C-N 120.729 1.604 . . . . 0.0 111.771 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 24.2 Cg_exo -57.9 88.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 123.421 2.747 . . . . 0.0 112.142 148.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -85.45 32.59 0.57 Allowed 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.77 -34.46 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.416 -0.802 . . . . 0.0 112.599 148.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 19' ' ' PRO . 17.9 p -68.3 8.22 0.48 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 118.763 2.875 . . . . 0.0 118.763 162.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -44.44 156.57 0.33 Allowed Pre-proline 0 CA--C 1.57 1.726 0 N-CA-C 119.211 3.041 . . . . 0.0 119.211 177.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -113.51 19.15 1.99 Allowed 'Cis proline' 0 C--N 1.37 1.661 0 N-CA-C 119.83 2.973 . . . . 0.0 119.83 11.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -67.48 -37.47 82.93 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 161.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.468 ' SG ' ' CE1' ' A' ' 17' ' ' TYR 0.293 14.2 p 49.56 57.05 6.93 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.528 1.531 . . . . 0.0 112.139 -166.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -86.07 148.69 48.46 Favored Pre-proline 0 N--CA 1.482 1.156 0 CA-C-O 116.813 -1.565 . . . . 0.0 113.678 -150.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.49 -12.54 0.19 Allowed 'Trans proline' 0 CA--C 1.564 1.991 0 N-CA-C 121.856 3.752 . . . . 0.0 121.856 171.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.4 t -96.97 -33.47 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 167.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.68 -38.77 86.05 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 160.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.8 m -73.46 -52.01 15.18 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 125.043 1.337 . . . . 0.0 113.746 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -126.58 83.52 64.61 Favored Pre-proline 0 CA--C 1.569 1.686 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -166.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.16 123.15 5.49 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.794 2.329 . . . . 0.0 113.038 -171.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.444 0 O-C-N 119.834 -1.791 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.271 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -82.13 160.94 18.0 Favored 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 124.574 3.516 . . . . 0.0 114.536 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.8 m -85.8 -48.96 8.3 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 37.27 49.22 1.62 Allowed Glycine 0 N--CA 1.485 1.926 0 N-CA-C 121.227 3.251 . . . . 0.0 121.227 -171.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 t -162.43 -50.07 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.416 0.686 . . . . 0.0 112.357 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.27 1.4 p90 -96.28 1.9 52.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 168.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.35 150.54 14.92 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 120.718 1.599 . . . . 0.0 111.458 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -53.34 100.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 123.441 2.761 . . . . 0.0 112.665 148.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.9 p -86.93 23.39 1.76 Allowed 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.9 m -70.71 -35.03 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 144.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 22' ' ' CYS . 33.6 t -79.46 25.04 0.33 Allowed 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 162.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.51 161.99 38.48 Favored Pre-proline 0 CA--C 1.569 1.705 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 171.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -110.72 18.92 3.72 Favored 'Cis proline' 0 C--N 1.369 1.606 0 N-CA-C 119.39 2.804 . . . . 0.0 119.39 6.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.26 -38.54 90.61 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 161.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.6 m 57.58 55.59 5.52 Favored 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 124.854 1.262 . . . . 0.0 111.035 -169.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.502 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -88.96 140.17 29.14 Favored Pre-proline 0 N--CA 1.481 1.076 0 CA-C-O 115.759 -2.067 . . . . 0.0 112.168 -149.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -36.72 -31.86 0.11 Allowed 'Trans proline' 0 N--CA 1.504 2.116 0 N-CA-C 121.088 3.457 . . . . 0.0 121.088 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.261 7.0 p -74.21 -41.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.22 -35.07 79.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 160.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 9.8 m -73.45 171.05 13.84 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 125.318 1.447 . . . . 0.0 113.205 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -127.4 130.69 23.67 Favored Pre-proline 0 CA--C 1.566 1.588 1 O-C-N 114.582 -5.074 . . . . 0.0 109.586 11.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.84 124.44 6.2 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.986 2.457 . . . . 0.0 112.978 -175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 O-C-N 119.968 -1.708 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -83.29 164.05 14.92 Favored 'Trans proline' 0 CA--C 1.561 1.828 0 C-N-CA 124.618 3.545 . . . . 0.0 114.558 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 80.1 m -90.31 -44.61 9.58 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.25 -77.83 1.99 Allowed Glycine 0 CA--C 1.539 1.551 0 N-CA-C 114.906 0.722 . . . . 0.0 114.906 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.5 t -74.34 -46.62 39.61 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 117.334 2.346 . . . . 0.0 117.334 -164.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.294 0.5 OUTLIER -87.01 -5.34 59.11 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 176.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -153.37 144.58 16.26 Favored Pre-proline 0 N--CA 1.485 1.283 0 CA-C-N 120.009 1.277 . . . . 0.0 110.764 -179.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -55.35 93.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 123.567 2.845 . . . . 0.0 111.867 148.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.7 m -94.1 35.25 1.18 Allowed 'General case' 0 CA--C 1.567 1.631 0 CA-C-N 114.507 -1.224 . . . . 0.0 113.406 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 64.6 t -76.33 -39.85 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.51 -0.744 . . . . 0.0 111.671 142.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.9 t -69.33 14.13 0.1 Allowed 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 117.002 2.223 . . . . 0.0 117.002 161.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -41.18 165.85 0.07 OUTLIER Pre-proline 0 CA--C 1.568 1.663 0 N-CA-C 120.244 3.424 . . . . 0.0 120.244 163.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -108.33 4.54 6.29 Favored 'Cis proline' 0 C--N 1.373 1.834 0 N-CA-C 120.626 3.279 . . . . 0.0 120.626 7.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.34 -22.2 62.82 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 117.484 2.401 . . . . 0.0 117.484 168.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.73 51.78 5.98 Favored 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 124.483 1.113 . . . . 0.0 112.288 -171.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.15 156.05 49.08 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 117.088 -1.434 . . . . 0.0 114.339 -151.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -61.69 2.89 0.46 Allowed 'Trans proline' 0 CA--C 1.568 2.224 0 N-CA-C 119.658 2.907 . . . . 0.0 119.658 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -106.32 -27.07 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 115.446 1.647 . . . . 0.0 115.446 161.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 72.5 m -60.09 -45.69 92.11 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.206 1.366 . . . . 0.0 114.05 155.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m -77.41 -47.18 20.45 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.27 1.428 . . . . 0.0 113.643 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -124.6 82.81 58.94 Favored Pre-proline 0 CA--C 1.567 1.612 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -173.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.06 -61.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.559 1.771 0 C-N-CA 122.816 2.344 . . . . 0.0 115.087 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.232 0 O-C-N 119.018 -2.301 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.322 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.29 168.48 24.7 Favored 'Trans proline' 0 CA--C 1.558 1.679 0 C-N-CA 124.647 3.565 . . . . 0.0 115.056 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 20' ' ' SER . 4.7 p -79.95 -55.11 5.2 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 172.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.08 -81.84 1.39 Allowed Glycine 0 CA--C 1.54 1.647 0 O-C-N 123.625 0.578 . . . . 0.0 114.039 -168.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -83.13 -39.45 21.05 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 117.919 2.562 . . . . 0.0 117.919 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' CD2' ' SG ' ' A' ' 18' ' ' CYS 0.321 0.9 OUTLIER -76.74 -21.89 54.61 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 174.587 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 76.8 m -153.8 148.5 19.6 Favored Pre-proline 0 CA--C 1.563 1.468 0 CA-C-N 119.109 0.868 . . . . 0.0 111.434 -171.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -51.81 107.58 0.19 Allowed 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 123.983 3.122 . . . . 0.0 113.488 155.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.58 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 67.3 p -90.97 36.72 0.91 Allowed 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 173.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.3 -40.96 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.478 155.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.1 15.07 0.12 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 118.436 2.754 . . . . 0.0 118.436 162.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -52.22 151.02 7.55 Favored Pre-proline 0 CA--C 1.565 1.539 0 N-CA-C 118.615 2.821 . . . . 0.0 118.615 -174.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -98.68 15.4 28.79 Favored 'Cis proline' 0 N--CA 1.494 1.515 0 N-CA-C 118.982 2.647 . . . . 0.0 118.982 3.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.33 82.27 1.82 Allowed 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 123.577 1.656 . . . . 0.0 107.609 159.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 93.5 m 27.24 36.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 120.269 3.433 . . . . 0.0 120.269 71.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -106.65 154.16 40.21 Favored Pre-proline 0 N--CA 1.482 1.159 0 CA-C-N 112.054 -2.339 . . . . 0.0 113.319 -159.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.66 -19.03 0.4 Allowed 'Trans proline' 0 CA--C 1.563 1.941 0 N-CA-C 122.336 3.937 . . . . 0.0 122.336 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.6 p -86.74 -42.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 165.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.8 t -63.43 -36.54 84.08 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.2 m -71.34 -49.72 39.57 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.801 1.241 . . . . 0.0 113.966 170.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -126.02 85.85 58.82 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.39 124.08 5.74 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.756 2.304 . . . . 0.0 112.975 -173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.469 0 O-C-N 120.005 -1.684 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.284 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -76.44 -79.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.606 0 C-N-CA 124.976 3.784 . . . . 0.0 114.254 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -134.67 -71.36 0.49 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.51 0.724 . . . . 0.0 111.341 179.544 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 46.15 68.05 1.17 Allowed Glycine 0 CA--C 1.551 2.309 0 N-CA-C 117.235 1.654 . . . . 0.0 117.235 -170.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.4 t -160.07 90.44 0.9 Allowed 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.415 30.3 p90 55.01 11.69 0.53 Allowed 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 -173.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -129.49 150.18 74.92 Favored Pre-proline 0 N--CA 1.492 1.666 0 CA-C-N 119.824 1.193 . . . . 0.0 113.504 -169.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.15 99.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.332 2.688 . . . . 0.0 111.828 142.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.2 p -74.73 12.9 0.72 Allowed 'General case' 0 CA--C 1.562 1.442 0 N-CA-C 117.448 2.388 . . . . 0.0 117.448 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.7 m -66.23 -26.76 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 153.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.4 p -108.37 58.0 0.61 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 123.208 1.48 . . . . 0.0 114.009 153.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.96 165.41 1.79 Allowed Pre-proline 0 CA--C 1.578 2.021 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 145.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -114.14 12.09 2.09 Favored 'Cis proline' 0 CA--C 1.56 1.782 0 N-CA-C 119.839 2.977 . . . . 0.0 119.839 8.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -70.51 -27.65 64.35 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 162.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 65.97 59.57 0.7 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.592 1.157 . . . . 0.0 108.258 -166.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -89.87 143.1 29.6 Favored Pre-proline 0 N--CA 1.483 1.204 0 CA-C-O 116.627 -1.654 . . . . 0.0 113.635 -146.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -50.43 -13.69 0.83 Allowed 'Trans proline' 0 CA--C 1.568 2.187 0 N-CA-C 120.964 3.409 . . . . 0.0 120.964 169.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.4 m -100.07 -29.9 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.4 t -61.26 -40.66 94.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 160.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 2.8 m -74.45 -51.16 15.67 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 125.238 1.415 . . . . 0.0 113.843 173.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -125.12 84.74 58.94 Favored Pre-proline 0 CA--C 1.567 1.613 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -166.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.22 125.41 6.42 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.567 2.178 . . . . 0.0 113.207 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.488 0 O-C-N 120.119 -1.613 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.273 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -82.58 160.58 16.81 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 C-N-CA 124.413 3.409 . . . . 0.0 114.424 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.9 m -93.4 -37.29 12.06 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.62 -84.06 1.6 Allowed Glycine 0 CA--C 1.538 1.528 0 N-CA-C 114.434 0.533 . . . . 0.0 114.434 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.4 m -83.49 -40.11 19.64 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.511 2.412 . . . . 0.0 117.511 -162.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . 0.309 0.6 OUTLIER -83.78 -8.95 59.12 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.55 149.95 25.43 Favored Pre-proline 0 N--CA 1.486 1.326 0 CA-C-N 120.058 1.299 . . . . 0.0 111.385 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -54.84 99.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 123.328 2.686 . . . . 0.0 112.229 149.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 94.4 p -87.84 23.2 2.09 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.31 -39.72 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.392 -0.817 . . . . 0.0 111.736 147.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.5 t -73.82 17.69 0.16 Allowed 'General case' 0 CA--C 1.58 2.123 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 162.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.58 165.75 0.21 Allowed Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 164.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -110.3 7.1 4.45 Favored 'Cis proline' 0 C--N 1.372 1.785 0 N-CA-C 120.698 3.307 . . . . 0.0 120.698 7.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -71.03 -25.16 62.54 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 117.177 2.288 . . . . 0.0 117.177 166.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.3 m 59.27 53.24 5.45 Favored 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 124.595 1.158 . . . . 0.0 112.091 -172.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.469 ' O ' ' SG ' ' A' ' 31' ' ' CYS . . . -93.42 155.49 40.79 Favored Pre-proline 0 N--CA 1.486 1.348 0 CA-C-O 117.035 -1.46 . . . . 0.0 114.264 -151.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -46.55 -14.22 0.13 Allowed 'Trans proline' 0 N--CA 1.504 2.118 0 N-CA-C 122.442 3.978 . . . . 0.0 122.442 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.0 t -101.23 -29.37 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 169.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.67 -46.61 86.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.624 1.556 . . . . 0.0 114.068 154.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 27' ' ' ALA . 1.6 m -86.11 150.22 24.58 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.755 1.622 . . . . 0.0 110.784 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.347 19.9 p90 51.41 73.38 0.98 Allowed Pre-proline 0 CA--C 1.577 2.009 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 166.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.98 123.78 5.85 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 C-N-CA 122.805 2.337 . . . . 0.0 112.741 -174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 O-C-N 119.96 -1.712 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_